Media Summary: CDER's Director of Division of Clinical Compliance Evaluation Ni A. Khin, M.D. defines good clinical practice ( This podcast based on an NSF white paper from expert Maxine Fritz provides an Jean Mulinde from CDER's Office of Scientific Investigations describes the casic characteristics of clinical trials of quality.
Overview Of Data Integrity 4of11 Gcp Data Integrity Workshop - Detailed Analysis & Overview
CDER's Director of Division of Clinical Compliance Evaluation Ni A. Khin, M.D. defines good clinical practice ( This podcast based on an NSF white paper from expert Maxine Fritz provides an Jean Mulinde from CDER's Office of Scientific Investigations describes the casic characteristics of clinical trials of quality. On October 20, 2017, Regis Technologies hosted a Protect your valuable data with these essential Cynthia F. Kleppinger from CDER's Office of Scientific Investigations describes what a
Stacey Bruzzese welcomes back Chris Wubbolt, Principal of QACV Consulting, to the show. Today, Stacey and Chris will be ... CDER's Deputy Center Director for Clinical Science Robert J. Temple, M.D., shares case studies and FDA perspectives on why ... Phillip D. Kronstein from CDER's Good Clinical Practice Assessment Branch provides a case study when a sponsor submitted an ... Since the widespread adoption of computer systems within the pharmaceutical, medical device, and biotech industries, In this video, we dive into one of the core pillars of Nilufer Tampal, PhD, Acting Deputy Director of the Office of Bioequivalence, discusses the FDA's bioequivalence
GxP-CC equips pharmaceutical and health sciences companies to comply with a complex array of regulations and quality ... In this episode, Stacey is joined by Felicia Ford-Rice, Senior Director Parexel International, the latest guidance from WHO about ... CDER's Director of the Division of Generic Drug Bioequivalence Evaluation Seongeun (Julia) Cho discusses bioequivalence ...
